Publication | Closed Access
Metabolism of the analgesic drug, tramadol hydrochloride, in rat and dog
100
Citations
10
References
2001
Year
Pain MedicinePharmacotherapyExperimental PharmacologyTramadol HydrochlorideMolecular PharmacologyMedicinal ChemistryAnesthesiaPharmacological StudyToxicologyPain ManagementAnesthetic PharmacologyAnimal PhysiologyDog Urine SamplesBiochemistryTotal RadioactivityAnalgesic DrugPharmacologyMetabolic PathwaysNatural SciencesPhysiologyForensic ToxicologyClinical PharmacologyMetabolismMedicinePharmacokineticsDrug Analysis
1. Metabolism of the analgesic agent, tramadol hydrochloride, was investigated after a single oral administration of 14C-tramadol to four rats (50)mgkg(-1) and two dogs (20)mg kg(-1). 2. Recovery of total radioactivity in rat and dog urine samples over 24 h was 73 and 65% of the radioactive dose, respectively. 3. Unchanged tramadol and a total of 24 metabolites, consisting of 16 Phase I metabolites and eight conjugates (seven glucuromides, one sulphate), were isolated and tentatively identified, which accounted for > 52% of the dose in urine of both species. 4. Of the metabolites, five (M1-5) were previously identified. 5. The metabolites were formed via the following six metabolic pathways: O-demethylation, N-demethylation, cyclohexyl oxidation, oxidative N-dealkylation, dehydration and conjugation. 6. Pathways 1-3 appear to be major steps, forming seven O-desmethyl/N-desmethyl and hydroxy-cyclohexyl metabolites in major quantities. 7. Pathways 1-3 in conjunction with pathway 6 produced four glucuronides along with four minor conjugates. 8. In addition, the in vitro metabolism of tramadol was conducted using rat hepatic S9 fraction in the presence of an NADPH-generating system. Unchanged tramadol (30% of the sample) plus nine metabolites, M1-7, tramadol-N-oxide (M31) and OH-cyclohexyl-M1 (M32), were profiled and tentatively identified based on MS and MS/MS data.
| Year | Citations | |
|---|---|---|
Page 1
Page 1